|Bid||1.35 x 0|
|Ask||1.39 x 0|
|Day's Range||1.27 - 1.45|
|52 Week Range||0.35 - 3.13|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
WKN: A1C4WM) today announced, in connection with the spin-out of its subsidiary Australis Capital Inc. ("Australis"), Australis has received a receipt for its final prospectus dated August 14, 2018 (the "Final Prospectus"). The Final Prospectus was filed with the securities regulatory authorities in all provinces and territories of Canada and is available under Australis' SEDAR profile at www.sedar.com. Receipt of the Final Prospectus will permit Aurora's Board of Directors (the "Board") to set the Record date of the transaction, which the company expects the Board will announce within the coming days. Additionally, Australis received conditional approval to list its shares and warrants on the Canadian Securities Exchange ("CSE"), as well as completed an oversubscribed private placement for proceeds of $17 million.
Project Aims to Study Outcomes of CBD Therapy for Pain Relief TSX: ACB MONTREAL , Aug. 16 , 2018 /CNW/ - Aurora Cannabis Inc. (" Aurora ") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt : 21P; WKN: ...
VANCOUVER, Aug. 15, 2018 /CNW/ - Hempco Food and Fiber Inc. (TSX.V:HEMP.V - News) ("Hempco®" or the "Company") today comments on Health Canada's publication of the Subsection 56(1) Class Exemption in relation to the use of hemp under Industrial Hemp regulations (flowering heads, leaves and branches). The exemption, published on August 10, 2018, enables companies with the relevant licenses to commence using the whole hemp plant for commercial purposes, which was prohibited under previous regulations.
WKN: A1C4WM) and Alcanna Inc. ("Alcanna") (TSX:CLIQ.TO - News) applaud the Ontario Government on its new plans for the responsible sale of recreational cannabis products through government-operated online sales, and the private sector. Aurora and Alcanna have entered into a license agreement which – as soon as regulations permit – will allow Alcanna to open retail cannabis stores under the brand name "Aurora".
WKN: A1C4WM) today announced that its acquisition of Anandia Laboratories Inc. ("Anandia") is now complete. The previously announced arrangement, under the provisions of the Business Corporations Act (British Columbia), means that among other things, Aurora has now acquired all of the issued and outstanding shares of Anandia in an all-share transaction (the "Transaction"). Anandia is a world-leading cannabis-focused science company, specialized in genomics, metabolite profiling, plant breeding, disease characterization, and cultivar certification, as well as providing testing services to producers and patient-cultivators.
WKN: A1C4WM) is pleased to provide the following update on its international operations. The Company has successfully shipped cultivars from its Mountain facility to Denmark to commence populating the Phase I Aurora Nordic facility, a 100,000 square foot, retrofitted hybrid greenhouse, which will be ramping up to full production capacity of 8,000 kg per year of medical cannabis over the coming months. Aurora Nordic is a 51%-Aurora owned subsidiary owned in partnership with Alfred Pederson & Son.
TSX: ACB EDMONTON , Aug. 10, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt : 21P; WKN: A1C4WM) is pleased to announce that Dr. Debra ...
NEW YORK, NY / ACCESSWIRE / August 9, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...
WKN: A1C4WM) and Alcanna Inc. ("Alcanna") (TSX:CLIQ.TO - News) today announced the companies have reached a license agreement whereby Alcanna has been given exclusive rights to open retail cannabis stores under the brand name "Aurora" across Canada. Alcanna's position as the biggest private sector liquor retailer in Canada, aligns with Aurora's position as one of the world's leading cannabis companies.
Further Strengthening Aurora's Technologically Advanced Hybrid Greenhouse Operations TSX: ACB EDMONTON , Aug. 7, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ...
New Authorization Will Facilitate Domestic and International Transport, Enhancing Global Distribution TSX: ACB EDMONTON , July 30, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") ...
TSX: ACB EDMONTON , July 28, 2018 /CNW/ - Further to the Company's press release dated July 24, 2018 , Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt ...
VANCOUVER, July 26, 2018 /CNW/ - Hempco Food and Fiber Inc. ("Hempco" of the "Company") (TSX-V:HEMP.V - News) today announced its results for the third quarter fiscal 2018 period ended May 31, 2018. Aurora Partnership: Aurora now holds 31,872,294 Hempco shares, or 52.5% of the issued and outstanding Hempco common shares, as at May 31, 2018. The partnership positions Hempco exceptionally well to capitalize on the opportunities for whole-plant utilization, including the extraction of CBD, under the new Cannabis Act from October 17, 2018 onwards, among others through Aurora`s strategic extraction partner Radient Technologies.
WKN: A1C4WM) and MedReleaf Corp. ("MedReleaf") (TSX:LEAF.TO - News) today announced the closing of the previously announced arrangement agreement (the "Arrangement Agreement"). Under the terms of the Arrangement Agreement, holders of MedReleaf common shares received 3.575 common shares of Aurora for each MedReleaf common share held (the "Exchange Ratio"). Upon closing of the transaction, Aurora will submit applications with the Toronto Stock Exchange (the "TSX") and the Ontario Securities Commission (the "OSC") to delist MedReleaf's existing common shares and for MedReleaf to cease to be a reporting issuer, respectively.
Company's New EU-Based Cannabis Production Facility Will Serve Maltese and EU Export Markets TSX: ACB EDMONTON , July 24, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") ...
Leading Benefit Providers Increasingly Offer Medical Cannabis Coverage TSX: ACB EDMONTON , July 23, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQB: ...
EDMONTON, July 18, 2018 /CNW/ - Aurora Cannabis Inc. (TSX:ACB.TO - News) (OTCQX:ACBFF - News) (Frankfurt: 21P;WKN:A1C4WM) ("Aurora" or the "Company") announces it has received shareholder approval at a special meeting, held today, for the issuance of shares in consideration for the planned acquisition of MedReleaf Corp. ("MedReleaf"), a well-known Canadian Licensed Producer based in Markham, Ontario that delivers premium medical cannabis products to domestic and global markets, and compelling brands to the adult-use recreational market. Low production costs and industry-leading yields: Aurora's automated 'Sky Class' greenhouses are expected to deliver industry-leading efficiencies and ultra-low production costs of well below $1 per gram, delivering sustainably robust margins.
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES ./ TSX: ACB ...
New ECommerce Platform to Benefit Both Medical and Adult-Consumer Use Customers TSX: ACB EDMONTON , July 16, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) ...
WKN: A1C4WM) announced today that the Company has entered into an agreement with Wagner Dimas Inc. ("Wagner Dimas") the transaction includes cash and the issuance of common shares of Aurora relative to the achievement of certain milestones for the joint commercialization of Wagner Dimas's technology. This technology targets the high-volume, higher-margin pre-rolled segment of the cannabis market.
WKN: A1C4WM) announced today that it has established a partnership agreement ("the Agreement") with Evio Beauty Group Ltd. ("Evio Beauty") pursuant to which Aurora has made a strategic investment in Evio Beauty. Under the terms of the Agreement, Aurora and Evio Beauty Group will collaborate to develop a line of co-branded hemp seed oil cosmetic products ("Non-Infused Products") as well as a collection of CBD infused cosmetic products ("Infused Products").
WKN: A1C4WM) and CannaRoyalty Corp. (CSE:CRZ.CN - News) (OTCQX:CNNRF - News) ("CannaRoyalty") (together the "Companies") today announced that the Companies have signed a binding term sheet (the "Agreement") whereby Aurora is purchasing CannaRoyalty's exclusive Canadian license to use and commercialize pre-roll technology developed by Wagner Dimas for an aggregate consideration of C$7 million in Aurora common shares (the "Purchase Price"). "Pre-rolls are a rapidly growing, in-demand segment of the international cannabis market and the Wagner Dimas's technology has substantial competitive advantages over peers in terms of throughput, quality and diversity," said Terry Booth, CEO of Aurora.
WKN: A1C4WM) is pleased to announce that Institutional Shareholder Services Inc. ("ISS") and Glass Lewis and Co., LLC ("Glass Lewis"), two leading advisory firms, have recommended that shareholders of Aurora vote for the Share Issuance Resolution with respect to the plan of arrangement to acquire all of the shares issued and outstanding of MedReleaf Corp. ("MedReleaf") (the "Transaction").
NEW YORK, NY / ACCESSWIRE / July 6, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with ...
TSX:ACB TSX:LEAF EDMONTON and MARKHAM, ON , July 6, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora") (TSX: ACB) (OTCQB: ACBFF) (Frankfurt : 21P; WKN: A1C4WM) and MedReleaf Corp. ("MedReleaf") ...